oncodaily - Eli Lilly and Company has announced the election of Carolyn R. Bertozzi, Ph.D., as a returning member of its Board of Directors, effective December 8, 2025. In her renewed role, […]
#healthcare #pharmaceuticals #elililly #biotech #drugdevelopment
Monday, December 15, 2025, 4:22 am / permalink 16960 / 2 stories in 2 months
Ella Jeffries / beckershospitalreview - The FDA has approved Waskyra (etuvetidigene autotemcel), the first gene therapy for Wiskott-Aldrich syndrome, a rare and life-threatening immune disorder. Waskyra is indicated for pediatric patients 6 months and older, as well as adults with Wiskott-Aldri…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Monday, December 15, 2025, 2:21 am / permalink 16954 / 4 stories in 2 months
Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours
Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.1 hours
White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours
MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.1 hours
Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours
Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours
Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours
Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours
Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: